NANJING, China, Nov. 14, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group (“Simcere” or the “Company”) (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
